These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


397 related items for PubMed ID: 21962963

  • 1. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [Abstract] [Full Text] [Related]

  • 2. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.
    Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
    [Abstract] [Full Text] [Related]

  • 3. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [Abstract] [Full Text] [Related]

  • 4. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A, Luisi S, De Leo V, Patton L, Gambineri A, Reis FM, Pasquali R, Petraglia F.
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [Abstract] [Full Text] [Related]

  • 5. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 6. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
    Moran LJ, Harrison CL, Hutchison SK, Stepto NK, Strauss BJ, Teede HJ.
    Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
    [Abstract] [Full Text] [Related]

  • 7. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    Fertil Steril; 2010 Oct; 94(5):1812-6. PubMed ID: 20004371
    [Abstract] [Full Text] [Related]

  • 8. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 9. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 10. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Stener-Victorin E, Baghaei F, Holm G, Janson PO, Olivecrona G, Lönn M, Mannerås-Holm L.
    Fertil Steril; 2012 Feb; 97(2):501-8. PubMed ID: 22154367
    [Abstract] [Full Text] [Related]

  • 11. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL, Buckley JD, Brinkworth GD.
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [Abstract] [Full Text] [Related]

  • 12. Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation.
    Liao LM, Nesic J, Chadwick PM, Brooke-Wavell K, Prelevic GM.
    Gynecol Endocrinol; 2008 Oct; 24(10):555-61. PubMed ID: 19012098
    [Abstract] [Full Text] [Related]

  • 13. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi G, Colao A, Vigorito C, Francesco O.
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [Abstract] [Full Text] [Related]

  • 14. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
    Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F.
    Hum Reprod; 2008 Mar; 23(3):642-50. PubMed ID: 18158291
    [Abstract] [Full Text] [Related]

  • 15. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 16. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 18. Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    Fertil Steril; 2010 Mar 01; 93(4):1173-8. PubMed ID: 19147136
    [Abstract] [Full Text] [Related]

  • 19. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul 01; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 20. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar 01; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.